Hepatitis C Virus Origins

1913 - The RF [Rockefeller Foundation] board on December 5 makes its first
grant: $100,000 to the American Red Cross for the purchase of property in
Washington, D.C., for its headquarters. Chronology
http://www.rockfound.org/frameset2.html

Mullins describes how the Rockefellers with the help of the American Medical
Association and government officials gained control of America's "health"
care industry in the early part of this century. "Educating" medical
students was instrumental in their plan, Mullins writes: "Rockefeller's
Education Board has spent more than $100 million to gain control of the
nation's medical schools and turn our physicians to physicians of the
allopathic school, dedicated to surgery and the heavy use of drugs."
Published by the National Council for Medical Research in 1988. Hard-cover,
348 pages. http://www.ioa.com/~davehart/

1915~1945 - Rockefeller - Yellow Fever - Aimed at yellow fever, RF's most
concentrated public health effort begins. Writes President Raymond B.
Fosdick later: "On no disease in the long list of human afflictions did the
Rockefeller Foundation put greater emphasis or a larger proportion of time
and financial support than on yellow fever." In this 30-year effort, RF
sends scientists throughout Africa and Latin America to conduct research and
test new approaches. Six die. Chronology
http://www.rockfound.org/frameset2.html

1969 - The original hemorrhagic fever: yellow fever. PMID: 4981419

1932 - The next step was to try inoculation on human beings; this was done
in 1932 by the Rockefeller group and by Sellards and Laigret in France - in
both cases with success. However, the use of the mouse vaccine was thought
to involve certain risks. This led Dr. Theiler and his collaborators, Lloyd,
Smith, and Ricci, to try to produce a vaccine less potentially dangerous.
After much hard work they achieved their purpose by means of a special
technique. This variant of the virus, which is quite harmless to man, was
called 17D. http://nobel.sdsc.edu/laureates/medicine-1951-press.html

1935 - Max Theiler - Vaccine to prevent yellow fever is developed in RF's
New York laboratories. http://www.rockfound.org/frameset2.html

1938 - In 1938 More than one million Brazilians were inoculated with the
vaccine before it was discovered that it had been contaminated with
hepatitis B virus. 330 000 people came down with hepatitis B virus infection
linked to vaccine lots given to approximately 50 000 US Army personnel.
There were at least 84 deaths from the 1942 hepatitis outbreak.
http://www.uow.edu.au/arts/sts/bmartin/dissent/documents/AIDS/El4.html

1976 - Brazil - Hepatitis B antigen (Australia antigen) in serum of yellow
fever patients. PMID: 1273407

1996 - Brazil - Concomitant high prevalence of hepatitis C virus antibodies
and hepatitis B virus markers in a small village of the Amazon Region,
Brazil. PMID: 9163988

1938 - Yellow fever vaccination with cultured virus (17D) without immune
serum. Am. J. Trop. Med. 18: 437-468.

1939 - Rockefeller Institute for Medical Research in New York studied the
virulent, unmodified strain of yellow fever virus, ostensibly for the
purpose of developing a cure for the disease. 1939 Japanese Army doctor,
Ryoichi Naito, [right-hand man of General S. Ishii] visited the laboratory
to obtain a sample of that strain of the Yellow Fever virus. It was
determined by Army Intelligence that Japan was interested in the yellow
fever virus for bacteriological warfare purposes.
http://www.tdbooks.com/ebooks/lastcircle/chpt15pt1.html

1940~1945 - During World War II, more than 140000 Allied prisoners of war
(POWs) were held captive by the Japanese in conditions of extreme privation.
The only exception is diseases of the liver, which may be due to infection
with hepatitis B or C virus during captivity. PMID: 10609817

Note:
1939~1945 - With increasing number of Japanese prisoners of war captured in
the South Pacific, the U.S. found out that not only was Japan engaged in
significant Biological research; its program was on a far larger scale than
previously suspected. Americans then knew that Tokyo was the center for
biological experimentation and that Ishii was the forerunner of Japanese
biological warfare with his epidemic prevention and water purification
headquarters at Harbin. Also known to the Americans, mainly from Japanese
naval sources, were the size of Unit 731 and germ bombs being manufactured.
http://www.aiipowmia.com/731study.html#Introduction

1947 - Under Gen. MacArthur's protection, the Japanese germ-war fare
researchers became some of Japan's most prominent citizens -- university
presidents, heads of medical centers. Lt. Col. Ryoichi Naito, Ishii's
right-hand man, founded Green Cross, one of Japan's top pharmaceutical
companies. Other Unit 731 leaders joined him there. On April 18, 1947, Gen.
MacArthur's headquarters issued an order - ''Every step, interrogation, or
contact must be coordinated with this section, The utmost secrecy is
essential in order to protect the interests of the United States and to
guard against embarrassment.''  http://kimsoft.com/korea/jp-germ.htm

Note:
Alpha Therapeutics Corporation: Defendant in the following suits brought by
infected victims: 1997: Louisiana (76 plaintiffs, represented by MULL &
MULL) Acquired in 1978 by GREEN CROSS and made a wholly-owned subsidiary.
Run by Thomas Drees from its acquisition until he resigned in 1983 when
Green Cross refused to address warnings issued by the CDC after meetings in
November, 1982 which clearly established the transmission of the then
unknown AIDS virus through blood.
http://www.freerepublic.com/forum/a375b24382eb6.htm

Note:
1939 - Mongolia - By 1939, Ishii's work bore fruits, as Unit 731 took part
in Japan's five-month war against the Soviet Union at Nomonhan in east Outer
Mongolia.  In late 1941, Ishii had successfully developed a germ bomb.  The
Japanese high command was ready to use biological warfare against China and
later against the United States.
http://www.acs.ucalgary.ca/~jhkeong/alpha_ww2_wu.html

1940's - A single lot of globulin prepared from plasma that was collected in
1944 from United States Army soldiers also contained detectable anti-delta.
These data indicate that delta-infection has been occurring among hepatitis
B surface antigen (HBsAg) carriers in the United States since the 1940s.
1984.  PMID: 6092192

1940's - There are very few reports of anaphylactic reactions to yellow
fever (YF) vaccine in the literature, and these date from the 1940s. YF
vaccine can cause anaphylactic reactions. 1999. PMID: 10200022

1941~1945 - WWII - Veterans - Vaccines - Unlicensed vaccines and bioweapon
defense in World War II. 1999. PMID: 10478686

2000 - VA - HCV Veterans - Era of service, 4.2% from WWII.
http://veterans.house.gov/hearings/schedule106/apr00/4-13ben/groselle.htm

1942 - Epidemic of hepatitis B in the U.S. Army. U.S. Army veterans given
yellow fever vaccine contaminated with hepatitis B virus in 1942. 69,988 men
were the subjects of the cohort study. The small excess liver cancer
mortality seen in the cohort study and the results of the case-control study
are consistent, nevertheless, with the now well-established etiological role
of hepatitis B virus infection in liver cancer. 1993. PMID: 8406352

1942 - Epidemic of post-vaccination hepatitis in the United States Army. An
epidemic of icteric hepatitis in 1942 affected approximately 50,000 U.S.
Army personnel. This outbreak was linked to specific lots of yellow-fever
vaccine stabilized with human serum. We conclude that hepatitis B caused the
outbreak, that about 330,000 persons may have been infected. 1987. PMID:
2436048

1976 - Brazil - Hepatitis B antigen (Australia antigen) in serum of yellow
fever patients. PMID: 1273407

1942 - Schering is once again taken over by the U.S. government following
the United States' entry into World War II. http://www.schering-plough.com

1942 - HBV - Yellow Fever - US Army - Dr Alwyn Zoutendyk, a respected member
of the staff of the South African Institute for Medical Research, attention
is called to the studies of the immunological disorders. While investigating
serum hepatitis affecting soldiers of the US army following the
administration of yellow fever vaccine [1942], an antigen similar to that
later called the Australia antigen, now hepatitis B surface antigen, was
found in the acute phase serum and the corresponding antibody was found in
convalescence. This finding and subsequent studies suggested there was a
group of disease, which we called the hyperreactive auto-allergic disorders,
of which examples were to be found in every system. The obverse of these we
called the hyporeactive immunologically deficient disorders resulting from
defects of the cell or serum components of the immunological reactions, of
which many examples have also been found. 1992. PMID: 1729733

1996 - Transfusion-associated hepatitis was recognized in 1943. PMID:
8800511

1977 - The efficacy of the ISG [Immune Serum Globulin], manufactured in
1944, against apparent type non-A, non-B hepatitis suggests that this
overlooked disease has existed from at least that time. The use of
commercial blood was observed to be the most important risk factor. PMID:
318578

1999 - A magic sword or a big itch: an historical look at the United States
biological weapons programme. In the late 1950s interest in entomological
warfare increased, and literature describing the US biological warfare
programmes on the use of the mosquito Aedes aegypti, the vector for
transmitting yellow fever, has now been released. Yellow fever was
considered as a suitable disease to use in southern regions of the former
Soviet Union. PMID: 10472190  Note: southern regions of the former Soviet
Union = Mongolia.

1997 - Southern USSR - Mongolia - HCV = 10.7% in Mongolia. The 1b genotype
predominated everywhere (68.9%), its incidence being the highest in Moldova
(96%). Unclassifiable variants of HCV were found in (6%) of sera. The
regularities of HCV genotypes circulation in the European Russia were the
same as in other European countries, whereas their prevalence in Eastern
Russia was rather like that in China or Japan. PMID: 9304294

2000 - VA - HCV Veterans - Era of service, 4.8% Korean conflict, 4.3%
post-Korean conflict.
http://veterans.house.gov/hearings/schedule106/apr00/4-13ben/groselle.htm

1949 -1954 - Mortality of Korean War Veterans Infected with Hepatitis C
Virus. A cohort of approximately 100 veterans have been identified as
Hepatitis C Virus (HCV) infected by testing a collection of serum specimens
collected from approximately 9,500 military recruits during the period 1949
to 1954. http://www2.nas.edu/mfua/2172.html

1954-1963 - Serum hepatitis at the Veterans Administration Research
Hospital, Chicago 1954-1963. PMID: 5958905

1958-1967 - Serum hepatitis at Henry Ford Hospital, 1958-1967. 1970 PMID:
5418757

1964 - Rockefeller Foundation's virus research program (successor to the
yellow fever vaccine campaign) is transferred to Yale University as the Yale
Arbovirus Research Unit. Chronology http://www.rockfound.org/frameset2.html

1965 - Japan - Symposium on serum hepatitis. Chronic hepatitis caused by
serum hepatitis. PMID: 5894570

1974 - FBI, FDA Documents obtained by Washington Weekly, Magnussen, 4/18/99.
Documents evidence 1974 investigations into the plasma distribution in the
U.S. and Canada by Continental Pharma Cryosan.
http://www.freerepublic.com/forum/a375b2b76399a.htm

1974 - Non A, Non-B, Hepatitis disclosed by the CDC.

2000 - VA - HCV Veterans - Era of service, 62.7% Vietnam era. Post-Vietnam
at 18.2%.
http://veterans.house.gov/hearings/schedule106/apr00/4-13ben/groselle.htm

1980 - Virus hepatitis, an overview - It has now been known for 40 years
that the particular liver disease which has been called "icterus
catarrhalis" in former times is being caused by virus infection. Before
that, Virchow's thesis ("occlusion of the papilla by mucus"), and later on
Eppinger's thesis ("serous hepatitis due to intoxication by unidentified
protein break-down products") were held to be true. Only after liver biopsy
was introduced became it known that this particular disease is in fact an
inflammatory process. Since neither bacteria nor protozoa could be found, it
had to be assumed that viruses were the positive agents. It then took
another 30 years until two viruses causing hepatitis (A and B) could be
identified. The most important steps in this process of identification were:
(1) proof of the oral and parental route of infection by Voegt in Germany
and by American authors (following yellow fever vaccination in the US Army);
(2) detection of the Australia (HBS) antigen by Blumberg; and (3) transfer
of the infectious disease to monkeys.In conclusion, the present day status
of hepatitis research (virology, epidemiology, immunology) is presented and
chances of prevention are discussed. PMID: 7432072

1986 - Simultaneous administration of hepatitis B and yellow fever vaccines.
Since no untoward reactions were noted, it is concluded that hepatitis B and
yellow fever vaccines can be administered at the same time. PMID: 2943870

2000 - (HCC) is increasing in many countries as a result of an increase in
(HCV) infection since World War II. PMID: 10728807

1999 - Most [HCV] infected persons are younger than 50 years old. PMID:
10622567

2000 - Persons born between 1940 and 1965 will be at highest lifetime risk
of acquiring HCV. PMID: 10706572

1987 - Descriptive epidemiology of an outbreak of hepatitis B in the U.S.
Army, Europe. PMID: 3112631

1987 - Post-transfusion hepatitis B virus [HCV] infection and effect of
prevention with hepatitis B immunoglobulin. PMID: 3443029.

1986 - Viral hepatitis, notably non-A non-B hepatitis, is the most frequent
infectious risk of transfusion in the United States today. The risk of HIV
infection is very low because of voluntary donor self-deferral and screening
of donated blood for evidence of the infection. PMID: 3786281

1990 - The Centers for Disease Control conducted intensive surveillance for
acute non-A, non-B hepatitis in four sentinel counties over a 7-year period.
There were significant changes in disease transmission patterns. The
proportion of patients with a history of blood transfusion declined from 17%
to 6%, but the proportion with a history of parenteral drug use increased
from 21% to 42%. PMID: 2170702

Note:
1998 - Sentinel Counties: Denver County, Colorado; Pierce County,
Washington; Jefferson County, Alabama; and Pinellas County, Florida. PMID:
9815207

1991 - CDC - Non-A, non-B hepatitis is more likely to occur outside the
transfusion setting. Surveillance data from the CDC show that in 1988
patients with non-A, non-B hepatitis reported a history of blood
transfusion, 2% medical or dental employment involving frequent blood
contact, less than 1% hemodialysis, and 40% no known source. High anti-HCV
rates (50-80%) in parenteral drug users and hemophiliacs, intermediate rates
among the sexually active (5-15%), and low rates among health care workers
(1%). PMID: 1656745

Hepatitis B Experiments
According to the Mortality and Morbidity Weekly Report, there were 358
reported cases of Hepatitis B in New York City and 438 cases in Upstate New
York for all of 1992. Despite CDC claims that there would be 200,000 cases
nationwide in 1992, there were, in fact, only 13,857 reported cases. The
vast majority of these cases were contracted through high-risk sex, drug
abuse and medical contact. Hepatitis B disease peaked in the mid 1980's and
has been declining ever since. Despite these facts, our legislators in
Albany are trying to mandate this vaccine for all newborn babies in New York
State. The vaccine has been added to the list of mandated vaccines for entry
to school.  (CONTINUES...)
http://www.trufax.org/vaccine/hepb.html
more chronology (broader focus, same elite criminals & cronies)
http://www.trufax.org/chrono/

2000 - VA  - HCV Veterans - Era of service, 2.7% Persian Gulf veterans.
http://veterans.house.gov/hearings/schedule106/apr00/4-13ben/groselle.htm

1992 - History of the research on differentiating Hepatitis A and B]. The
numerous researches devoted to 'jaundice' during the Second World War have
brought to light the existence of an infectious type of hepatic jaundice or
'homologous serum jaundice' following parenteral injection of vaccines
containing human serum and blood transfusions, which were carried out on a
large scale at the time. This type of serum jaundice was then gradually
differentiated from 'catarrhal', contagious or epidemic jaundice by clinical
trials along with large series of animal studies. Finally, the
epidemiological, clinical and biological data obtained made it possible to
establish, between 1944 and 1954, the viral etiology of these two types of
jaundice: the A virus, present in the patients' blood and stools, was
considered to be the agent responsible for epidemic hepatitis; the B virus,
present primarily in the blood, was held to be responsible for serum
hepatitis. PMID: 1308284

1997 - 1991 to 1994 - A four-year review of patients with hepatitis C
antibody in Department of Veterans Affairs facilities. [HCV] has recently
been recognized as an emerging pathogen of surprising proportions. From 1991
to 1994. This represents an increase of more than 285% during the 4-year
period. Increases in HCV antibody for the same period were seen in all major
regions of the United States and in the specified large metropolitan areas.
PMID: 9358714

1999 - HCV - Veterans - tests for hepatitis C conducted among veterans last
year [31%] were positive for the hepatitis C antibody. SOURCE: House
Committee on Veterans' Affairs
http://biz.yahoo.com/prnews/990416/dc_congres_1.html

Note:
1997 - 26 Million US Veterans - The present veteran population is estimated
at 25.6 [26] million, as of July 1, 1997.
http://www.va.gov/organization/Vavdva.htm

Note:
The Math - 26 million total veterans x 31% HCV veteran rate = more than 8
million veterans in the US with HCV.

2000 - HCV Veterans - Era of service, 4.2% from WWII, 4.8% Korean conflict,
4.3% post-Korean conflict, 62.7% Vietnam era. Post-Vietnam at 18.2%, 2.7%
Persian Gulf veterans.
http://veterans.house.gov/hearings/schedule106/apr00/4-13ben/groselle.htm

1999 - The U.S. Veteran population represents a unique patient group to
study different HCV genotypes because of geographically diverse exposures.
The aim of this study was to characterize the distribution of HCV genotypes
in U.S. veterans undergoing liver transplantation (OLT). (45%) patients had
serological evidence of prior hepatitis B (HBV) infection. PMID: 10520862

2000 - The major risk factors for this [HCC] cancer have been identified as
chronic infection with (HBV) and (HCV) viruses and dietary exposure to
aflatoxins. PMID: 10767647

1991 - NANB PTH is as common in Taiwan as in the United States and Japan,
and is demonstrated by this study to be due mostly to HCV. PMID: 1908889

1991 - US - Antibodies to HCV is 10.08% among commercial plasma donors.
PMID: 1709949

1974 - FBI, FDA Documents obtained by Washington Weekly, Magnussen, 4/18/99.
Documents evidence 1974 investigations into the plasma distribution in the
U.S. and Canada by Continental Pharma Cryosan.
http://www.freerepublic.com/forum/a375b2b76399a.htm

1974 - Non A, Non-B, [HCV] Hepatitis disclosed by the CDC.

1998 - June - CDC - Alter MJ - "There isn't a lot we've been able to do,"
says Miriam Alter, chief of epidemiology for hepatitis at the CDC. Alter
adds, "therapy has been very disappointing for most people." US News Cover
Story; 6/22/98. Hepatitis C: A silent killer BY NANCY SHUTE.
http://www.usnews.com/usnews/issue/980622/22hepc.htm

1998 - June - CDC - Alter MJ - Injection drug use is the single most
important risk factor for acquiring (HCV) infection. PMID: 9663617
[Published in an AIDS Publication]

1998 - Facing up to re-emergence of urban yellow fever. PMID: 10334247

2000 - Rockefeller Foundation Mission Statement - "Our highest priorities
include AIDS, malaria and tuberculosis."
http://www.rockfound.org/frameset2.html

2000 May - First Hepatitis-C Center in Northeast Region Established By
Rockefeller University, NewYork-Presbyterian, and Weill Cornell.
http://www.newswise.com/articles/2000/5/HEPC.RKU.html

May God Bless You and Keep You Well

Peter (Professor Ozone) Jovan

www.ozoneuniversity.com

www.ozonehospital.com

www.oxygentherapyexperts.com

604-501-6051 Phone

514-371-9778 Fax

Founder

Ozone Research Group

Skype ID - ozoneresearch

Yahoo Group Owner- http://groups.yahoo.com/group/oxyzone/

 

Without prejudice to the generality of the contents herein, this communication does not attach any legal liability on the originator thereof. This communication contains information, which is confidential and may also be privileged. It is for the exclusive use of the intended recipient(s). If you have received this communication by error, please delete the email and destroy any copies of it.